Indian Imatinib Exporters: Complete Supplier Ranking with Market Share — 456 Manufacturers (2026) — TransData Nexus

Q: Who is the largest imatinib buyer importing from India?

H.ESSERS & ZONEN INTERNATIONAL TRAN (BELGIUM) is the largest imatinib importer from India with a 11.4% market share and import value of $3.3M.

Q: How many imatinib buyers import from India?

There are 456 active imatinib buyers importing from India, with a combined import market of $29.3M across 1,726 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top imatinib buyers from India?

The top 5 imatinib buyers — H.ESSERS & ZONEN INTERNATIONAL TRAN, COOPER PHARMA, AUROLOGISTICS LLC, (AUROBINDO PHARM, AUROBINDO PHARMA USA INC, OOO"JODAS EXPOIM" — together control 33.8% of total imatinib import value from India.

Suresh Sormare

Imatinib

India Pharmaceutical Trade Intelligence

$29.3M224 Suppliers119 CountriesHS 30049049

ExportsIndia → UNITED STATES24.3%India → BELGIUM12.4%

ImportsGERMANY → India$331.7M UNITED STATES → India$584.7K

#1 Supplier: CIPLA LIMITED #1 Buyer: H.ESSERS &

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $7.1M through 100 shipments. This represents a market share of 24.3% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• AUROLOGISTICS LLC, (AUROBINDO PHARM - $1.8M (25.2% of country's total business)

• AUROBINDO PHARMA USA INC - $1.5M (21.6% of country's total business)

• AUROBINDO PHARMA USA., INC, - $1.2M (16.8% of country's total business)

• QUALLENT PHARMACEUTICALS HEALTH LLC - $553.2K (7.8% of country's total business)

• AUROBINDO PHARMA USA., INC - $476.1K (6.7% of country's total business)

• Rest of United States's importers - $1.6M (21.9% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $71.1K, indicating premium pricing strategy compared to the market average of $17.0K.

United States is a key market for Imatinib imports, representing 24.3% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Imatinib buyer market intelligence

1Buyer Segment Analysis

The importation of Imatinib from India involves a diverse array of buyers, each falling into specific categories:

Distributors: Entities like H. Essers & Zonen International Transport (Belgium) and Cooper Pharma (Morocco) function as intermediaries, purchasing large quantities of Imatinib to supply regional markets. Their buying behavior is characterized by bulk orders and a focus on maintaining a steady supply chain to meet market demand.

Contract Manufacturers: Companies such as Aurobindo Pharma USA Inc. and Aurobindo Pharma USA., Inc. (United States) import Imatinib for further processing or formulation. Their procurement patterns are aligned with production schedules, often involving substantial volumes to ensure continuous manufacturing operations.

Re-exporters: Firms like OOO "Jodas Expoim" (Russia) and OOO Jodas Expoim (Russia) may import Imatinib with the intent to re-export to neighboring markets. Their purchasing behavior is influenced by regional demand fluctuations and trade agreements, leading to variable order sizes and frequencies.

Financial Institutions: Entities such as Habib Bank Limited and JS Bank Ltd. (Pakistan) are listed among the top buyers. While not traditional pharmaceutical buyers, their involvement suggests roles in facilitating large-scale procurement, possibly for government or large healthcare institutions. Their buying patterns would be characterized by significant, periodic transactions aligned with institutional needs.

Country-Specific Import Regulations

TransData Nexus Imatinib buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process for Imatinib: Importers must ensure that Imatinib is FDA-approved. The process involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generics.

3. Estimated Timeline for Registration: The FDA review process typically takes 10 months for standard applications, though priority reviews can be expedited to 6 months.

4. Import Tariff/Duty for HS 30049049: Pharmaceutical products under HS code 30049049 are generally duty-free in the U.S.

Belgium

1. Drug Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).

2. Import Registration Process for Imatinib: Importers must obtain a marketing authorization from FAMHP, which includes submitting a dossier demonstrating the product's quality, safety, and efficacy.

3. Estimated Timeline for Registration: The evaluation process can take up to 210 days, excluding any clock stops for additional information requests.

4. Import Tariff/Duty for HS 30049049: As part of the European Union, Belgium applies a 0% tariff on pharmaceutical products under this HS code.

Pakistan

1. Drug Regulatory Authority: Drug Regulatory Authority of Pakistan (DRAP).

2. Import Registration Process for Imatinib: Importers must register the product with DRAP by submitting an application that includes product details, manufacturing information, and evidence of compliance with quality standards.

3. Estimated Timeline for Registration: The registration process can take approximately 12 to 18 months, depending on the completeness of the application and any additional information required.

Demand Drivers & Market Opportunity

TransData Nexus Imatinib buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Imatinib across various countries is primarily driven by the prevalence of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST), conditions for which Imatinib is a first-line treatment. According to the World Health Organization (WHO), CML accounts for approximately 15% of all leukemia cases worldwide, indicating a significant patient population requiring Imatinib therapy.

Government healthcare programs and the expansion of universal health coverage have further bolstered demand. Many countries have included Imatinib in their national essential medicines lists, aligning with the WHO Model List of Essential Medicines, which recommends Imatinib for the treatment of CML and GIST. This inclusion facilitates procurement through government tenders and international organizations like UNICEF and the Global Fund, ensuring broader access to the medication. The presence of 456 buyers across 119 countries, as per TransData Nexus data, underscores the global reach and critical need for Imatinib in managing these life-threatening conditions.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Imatinib Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest imatinib buyer importing from India?

Based on import volume and value, H.ESSERS & ZONEN INTERNATIONAL TRAN (BELGIUM) leads with $3.3M in imports and a 11.4% market share — the highest of any single imatinib importer. COOPER PHARMA (MOROCCO) and AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES) are the next largest buyers.

QHow many companies buy imatinib from India?

There are 456 active imatinib buyers importing from India, with a combined market of $29.3M across 1,726 shipments to 119 countries. The top 5 buyers hold 33.8% of total import value, while the remaining 451 buyers handle the other 66.2%.

QWhich countries import the most imatinib from India?

The top importing countries for imatinib from India are United States (24.3%), Belgium (12.4%), Pakistan (11.1%), Russia (9.1%), Morocco (8.2%). These markets represent the largest demand centres for Indian pharmaceutical exports of imatinib, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for imatinib from India?

The average import transaction value for imatinib from India is $17.0K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Imatinib buyer market intelligence

1Buyer Segment Analysis

The importation of Imatinib from India involves a diverse array of buyers, each falling into specific categories:

Distributors: Entities like H. Essers & Zonen International Transport (Belgium) and Cooper Pharma (Morocco) function as intermediaries, purchasing large quantities of Imatinib to supply regional markets. Their buying behavior is characterized by bulk orders and a focus on maintaining a steady supply chain to meet market demand.

Contract Manufacturers: Companies such as Aurobindo Pharma USA Inc. and Aurobindo Pharma USA., Inc. (United States) import Imatinib for further processing or formulation. Their procurement patterns are aligned with production schedules, often involving substantial volumes to ensure continuous manufacturing operations.

Re-exporters: Firms like OOO "Jodas Expoim" (Russia) and OOO Jodas Expoim (Russia) may import Imatinib with the intent to re-export to neighboring markets. Their purchasing behavior is influenced by regional demand fluctuations and trade agreements, leading to variable order sizes and frequencies.

Financial Institutions: Entities such as Habib Bank Limited and JS Bank Ltd. (Pakistan) are listed among the top buyers. While not traditional pharmaceutical buyers, their involvement suggests roles in facilitating large-scale procurement, possibly for government or large healthcare institutions. Their buying patterns would be characterized by significant, periodic transactions aligned with institutional needs.

Country-Specific Import Regulations

TransData Nexus Imatinib buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

3. Estimated Timeline for Registration: The FDA review process typically takes 10 months for standard applications, though priority reviews can be expedited to 6 months.

4. Import Tariff/Duty for HS 30049049: Pharmaceutical products under HS code 30049049 are generally duty-free in the U.S.

Belgium

1. Drug Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).

2. Import Registration Process for Imatinib: Importers must obtain a marketing authorization from FAMHP, which includes submitting a dossier demonstrating the product's quality, safety, and efficacy.

3. Estimated Timeline for Registration: The evaluation process can take up to 210 days, excluding any clock stops for additional information requests.

4. Import Tariff/Duty for HS 30049049: As part of the European Union, Belgium applies a 0% tariff on pharmaceutical products under this HS code.

Pakistan

1. Drug Regulatory Authority: Drug Regulatory Authority of Pakistan (DRAP).

3. Estimated Timeline for Registration: The registration process can take approximately 12 to 18 months, depending on the completeness of the application and any additional information required.

Demand Drivers & Market Opportunity

TransData Nexus Imatinib buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Imatinib

Imatinib

Who Buys Imatinib from India — 456 Importers Behind a $29.3M Market

Top Imatinib Importers — Ranked by Import Value

Top Imatinib Buyers & Importers

Related Analysis

Need Details?

Imatinib — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Imatinib — and from which countries?

Imatinib — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Imatinib Buyers & Importers

QWho is the largest imatinib buyer importing from India?

QHow many companies buy imatinib from India?

QWhich countries import the most imatinib from India?

QWhat is the average import order value for imatinib from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Belgium

3Pakistan

4Russia

5Morocco

Analysis Methodology